Clinical use of dendritic cells for cancer therapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2014-06-01 / Lancet Oncol. 2014 Jun;15(7):e257-67Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2014-03-05 / Sci Transl Med 2014 Mar;6(226):226ra32Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2013-12-03 / Front Immunol 2013 Dec;4:417Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2013-03-21 / Cancer Lett. 2013 Aug;336(2):253-9The blockade of immune checkpoints in cancer immunotherapy
/in Checkpoint-Inhibitors, International Publications /von 2012-03-22 / Nat. Rev. Cancer 2012 Mar;12(4):252-64PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2011-06-01 / J. Immunother. 2011 Jun;34(5):409-18Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de